Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH-ubiquinone oxidoreductase (complex I) is the first and largest enzyme complex of the mitochondrial respiratory chain. It is embedded in the inner mitochondrial membrane and consists of at least 45 subunits in mammals, encoded by both nuclear and mitochondrial DNA. Its core function is to transfer electrons from NADH to ubiquinone (coenzyme Q), coupled with the translocation of protons across the inner mitochondrial membrane, helping generate the proton gradient used for ATP production through oxidative phosphorylation. Defects or inhibition of complex I can lead to mitochondrial diseases, contribute to neurodegenerative and cardiovascular diseases, and increase cellular oxidative stress[1][3][5][4][7]. Note on correctness ("is_incorrect"): "NADH dehydrogenase chain I" by itself is not a standard canonical target name; it is ambiguous, as it can refer to: - The ND1 subunit (NADH-ubiquinone oxidoreductase chain 1, often abbreviated as ND1), which is one mitochondrial DNA-encoded subunit of mitochondrial complex I (the whole enzyme complex)[8][6]. - The entire enzyme complex ("NADH-ubiquinone oxidoreductase", "complex I", or "respiratory complex I"), which is a large multi-subunit enzyme[3][4][1]. For most scientific or therapeutic targeting, the relevant entity is the entire NADH-ubiquinone oxidoreductase (complex I), not an individual subunit. If the intent is the subunit ND1, the canonical name should be "NADH-ubiquinone oxidoreductase chain 1 (ND1)"; if the intent is the whole enzyme, it should be "NADH-ubiquinone oxidoreductase (complex I)". The provided name "NADH dehydrogenase chain I" thus lacks specificity and does not follow accepted protein/gene nomenclature, and is flagged as potentially incorrect due to ambiguity and non-standard naming[6][8].
Inhibition of electron transport (e.g., by rotenone/piericidin A, which block electron transfer from NADH to ubiquinone) Modulation of mitochondrial reactive oxygen species (ROS) production
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH-ubiquinone oxidoreductase chain I.